F. Joly, B. Giffard, and O. Rigal, Impact of cancer and its treatments on cognitive function: advances in research from the Paris international cognition and cancer task force symposium and update since 2012, J Pain Symptom Manage, vol.50, pp.830-841, 2015.

N. Boykoff, M. Moieni, and S. K. Subramanian, Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response, J Cancer Surviv, vol.3, pp.223-232, 2009.

K. Nieuwenhuijsen, A. De-boer, E. Spelten, M. A. Sprangers, and J. H. Verbeek, The role of neuropsychological functioning in cancer survivors' return to work one year after diagnosis, Psycho-Oncology, vol.18, pp.589-597, 2009.

V. Ah, D. Habermann, B. Carpenter, J. S. Schneider, and B. L. , Impact of perceived cognitive impairment in breast cancer survivors, Eur J Oncol Nurs, vol.17, pp.236-241, 2013.

M. J. Pullens, D. Vries, J. Roukema, and J. A. , Subjective cognitive dysfunction in breast cancer patients: a systematic review, PsychoOncology, vol.19, pp.1127-1138, 2010.

E. O'farrell, A. Smith, and B. Collins, Objective-subjective disparity in cancer-related cognitive impairment: does the use of change measures help reconcile the difference? Psychooncology, 2016.

H. M. Dhillon, I. F. Tannock, G. R. Pond, C. Renton, S. B. Rourke et al., Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy, J Cancer Surviv, 2017.

J. S. Mandelblatt, J. D. Clapp, and G. Luta, Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance), 2016.

|. Lange-et and A. L. ,

N. D. Buchanan, S. Dasari, and J. L. Rodriguez, Post-treatment neurocognition and psychosocial care among breast cancer survivors, Am J Prev Med, vol.49, pp.498-508, 2015.

J. E. Schmidt, E. Beckjord, and D. H. Bovbjerg, Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey, J Cancer Surviv, vol.10, pp.302-311, 2016.

M. C. Janelsins, C. E. Heckler, and L. J. Peppone, Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study, J Clin Oncol, vol.35, pp.506-514, 2017.

F. Munir, J. Burrows, J. Yarker, K. Kalawsky, and M. Bains, Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study, J Clin Nurs, vol.19, pp.1362-1370, 2010.

L. Fel, J. Daireaux, A. Vandenbosshe, and S. , Impact of cancer treatments on cognitive functions: the patients' view, their expectation and their interest in participating to cognitive rehabilitation workshops, Bull Cancer, vol.100, pp.223-229, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01782373

C. Bauquier, P. M. Preau, and M. , The Seintinelles: an innovative approach to promoting Community-Based Research and sustaining health democracy in oncology

, Sante Publique, vol.29, pp.547-550, 2017.

M. B. Veierød, S. Lydersen, and P. Laake, Medical statistics in clinical and epidemiological research

N. Oslo, , 2012.

M. Da-silva, E. Weiderpass, I. Licaj, and C. Rylander, Factors Associated with High Weight Gain and Obesity Duration: The Norwegian Women and Cancer (NOWAC) Study, Obes Facts, vol.11, pp.381-392, 2018.

M. C. Janelsins, S. Kohli, S. G. Mohile, K. Usuki, T. A. Ahles et al., An update on cancer-and chemotherapy-related cognitive dysfunction: current status, Semin Oncol, vol.38, pp.431-438, 2011.

M. Lange and F. Joly, How to identify and manage cognitive dysfunction after breast cancer treatment, J Oncol Pract, vol.13, pp.784-790, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02094003

M. Lange, N. Heutte, and O. Rigal, Decline in cognitive functions in elderly early-stage breast cancer patients after adjuvant treatment, Oncologist, vol.21, pp.1337-1348, 2016.

K. Hermelink, H. Küchenhoff, and M. Untch, Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study, Psycho-Oncology, vol.19, pp.1321-1328, 2010.

A. Amidi, S. Christensen, M. Mehlsen, A. B. Jensen, A. D. Pedersen et al., Long-term subjective cognitive functioning following adjuvant systemic treatment: 7-9 years follow-up of a nationwide cohort of women treated for primary breast cancer, Br J Cancer, vol.113, pp.794-801, 2015.

Y. Leng, C. T. Mcevoy, I. E. Allen, and K. Yaffe, Association of sleep-disordered breathing with cognitive function and risk of cognitive impairment: a systematic review and meta-analysis, JAMA Neurol, vol.74, pp.1237-1245, 2017.

E. Altena, J. R. Ramautar, Y. D. Van-der-werf, and E. J. Van-someren, Do sleep complaints contribute to age-related cognitive decline?, Prog Brain Res, vol.185, pp.181-205, 2010.

V. Ah, D. Tallman, and E. F. , Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument, J Pain Symptom Manage, vol.49, pp.697-706, 2015.

T. Ng, S. R. Dorajoo, and Y. T. Cheung, Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian breast cancer survivors, Psychooncology, vol.27, pp.1185-1192, 2018.

J. L. Vardy, V. J. Bray, and H. M. Dhillon, Cancer-induced cognitive impairment: practical solutions to reduce and manage the challenge, Future Oncol, vol.13, pp.767-771, 2017.

S. B. Schagen, E. Das, and I. Vermeulen, Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients, Psycho-Oncology, vol.21, pp.1132-1135, 2012.

S. R. Jacobs, P. B. Jacobsen, M. Booth-jones, L. I. Wagner, and C. Anasetti, Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoietic stem cell transplant patients, J Pain Symptom Manage, vol.33, pp.13-23, 2007.

S. B. Schagen, E. Das, and F. S. Van-dam, The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients, Psycho-Oncology, vol.18, pp.674-678, 2009.

W. Jacobs, E. Das, and S. B. Schagen, Increased cognitive problem reporting after information about chemotherapy-induced cognitive decline: The moderating role of stigma consciousness, Psychol Health, vol.32, pp.78-93, 2017.

L. M. Reid and A. M. Maclullich, Subjective memory complaints and cognitive impairment in older people, Dement Geriatr Cogn Disord, vol.22, pp.471-485, 2006.

J. S. Myers, J. A. Wick, and J. Klemp, Potential factors associated with perceived cognitive impairment in breast cancer survivors, Support Care Cancer, vol.23, pp.3219-3228, 2015.

R. J. Chan, A. L. Mccarthy, J. Devenish, K. A. Sullivan, and A. Chan, Systematic review of pharmacologic and non-pharmacologic interventions to manage cognitive alterations after chemotherapy for breast cancer, Eur J Cancer, vol.51, pp.437-450, 2015.

V. J. Bray, H. M. Dhillon, and M. L. Bell, Evaluation of a web-based cognitive rehabilitation program in cancer survivors reporting cognitive symptoms after chemotherapy, J Clin Oncol, vol.35, pp.217-225, 2017.

E. Lm, L. Petersen, and H. Am, Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial, Psychooncology, vol.24, pp.1360-1367, 2015.

V. Ah, D. Carpenter, J. S. Saykin, and A. , Advanced cognitive training for breast cancer survivors: a randomized controlled trial, Breast Cancer Res Treat, vol.135, pp.799-809, 2012.

C. D. Runowicz, C. R. Leach, and N. L. Henry, American cancer society/American society of clinical oncology breast cancer survivorship care guideline, J Clin Oncol, vol.34, pp.611-635, 2016.

K. Smidt, L. Mackenzie, H. Dhillon, J. Vardy, J. Lewis et al., The perceptions of Australian oncologists about cognitive changes in cancer survivors, Support Care Cancer, vol.24, pp.4679-4687, 2016.